Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting the epidermal growth factor receptor.
El-Rayes BF, LoRusso PM. El-Rayes BF, et al. Among authors: lorusso pm. Br J Cancer. 2004 Aug 2;91(3):418-24. doi: 10.1038/sj.bjc.6601921. Br J Cancer. 2004. PMID: 15238978 Free PMC article. Review.
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.
LoRusso P, Wozniak AJ, Polin L, Capps D, Leopold WR, Werbel LM, Biernat L, Dan ME, Corbett TH. LoRusso P, et al. Cancer Res. 1990 Aug 15;50(16):4900-5. Cancer Res. 1990. PMID: 2165850
Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.
LoRusso PM, Aukerman SL, Polin L, Redman BG, Valdivieso M, Biernat L, Corbett TH. LoRusso PM, et al. Cancer Res. 1990 Sep 15;50(18):5876-82. Cancer Res. 1990. PMID: 2393858
Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne State University.
LoRusso P, Tapazoglou E, Kish JA, Ensley JF, Cummings G, Kelly J, al-Sarraf M. LoRusso P, et al. Cancer. 1988 Jul 1;62(1):1-5. doi: 10.1002/1097-0142(19880701)62:1<1::aid-cncr2820620102>3.0.co;2-f. Cancer. 1988. PMID: 2454717
Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.
Poplin EA, LoRusso P, Lokich JJ, Gullo JJ, Leming PD, Schulz JJ, Veach SR, McCulloch W, Baker L, Schein P. Poplin EA, et al. Cancer Chemother Pharmacol. 1994;33(5):415-9. doi: 10.1007/BF00686271. Cancer Chemother Pharmacol. 1994. PMID: 8306416 Clinical Trial.
Levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from blood as a marker of breast cancer.
Djuric Z, Heilbrun LK, Simon MS, Smith D, Luongo DA, LoRusso PM, Martino S. Djuric Z, et al. Among authors: lorusso pm. Cancer. 1996 Feb 15;77(4):691-6. Cancer. 1996. PMID: 8616761
Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.
Zalupski MM, Philip PA, LoRusso P, Shields AF. Zalupski MM, et al. Cancer Chemother Pharmacol. 1997;40(3):225-7. doi: 10.1007/s002800050650. Cancer Chemother Pharmacol. 1997. PMID: 9219505 Clinical Trial.
Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer.
Ramnath N, LoRusso P, Simon M, Martino S. Ramnath N, et al. Am J Clin Oncol. 1997 Aug;20(4):368-72. doi: 10.1097/00000421-199708000-00009. Am J Clin Oncol. 1997. PMID: 9256891 Clinical Trial.
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.
Foster BJ, Wiegand RA, Pugh S, LoRusso PM, Rake J, Corbett TH. Foster BJ, et al. Among authors: lorusso pm. Clin Cancer Res. 1997 Nov;3(11):2047-53. Clin Cancer Res. 1997. PMID: 9815596
169 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback